AD

Ankamma Devi Kotagiri

Active Director Director DIN 11254297
DIN 11254297 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankamma Devi Kotagiri

Data last updated:

Ankamma Devi Kotagiri is a Director at Crestone Pharmaceutical Private Limited (since 2025). The company operates in Pharma.

DIN 11254297
Primary Designation Director
Industry Pharma
First Appointment 23 Jul 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jul 2025Active

Board colleagues of Ankamma Devi Kotagiri

Directorship timeline

Open interactive timeline →
Crestone Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ankamma Devi Kotagiri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankamma Devi Kotagiri

Ankamma Devi Kotagiri currently holds 1 directorship: Crestone Pharmaceutical Private Limited (Director, since 23 Jul 2025).

Ankamma Devi Kotagiri was first appointed on 23 Jul 2025 as Director at Crestone Pharmaceutical Private Limited.

The current boards of Ankamma Devi Kotagiri's companies include Botuku Lavanya (Crestone Pharmaceutical Private Limited), Jarugula China Venkayamma (Crestone Pharmaceutical Private Limited), Jyothi Sirigiri (Crestone Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available